caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1609309038

Stanley CooperMD

Infectious DiseaseNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
3,731
Beneficiaries
—
Total drug cost
$4.8M
Distinct drugs
94
Brand share
52.7%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala493 claims
Atorvastatin Calcium191 claims
Dolutegravir Sodium161 claims
Valacyclovir Hcl128 claims
Albuterol Sulfate127 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
105
Unique beneficiaries
—
Total services
169
Distinct HCPCS
4
Medicare payment
$13K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 549 Infectious Disease providers in NY — below median (cohort median 348).